Kirk Stevens

Kirk Stevens has over 30 years of experience in the pharmaceutical industry. Kirk began their career in 1989 as a Research Assistant at UCLA. In 1996, they became an American Cancer Society PostDoctoral Fellow at Harvard University. In 1999, they joined GlaxoSmithKline as Program Leader. From 2009 to 2022, they worked at Gilead Sciences in roles such as Principal Scientist/Chemistry Lead and Senior Research Scientist. Since 2022, they have been employed at Vibliome Therapeutics, LLC as a Drug Hunter/3D Explorer/Lead Optimizer.

Kirk Stevens completed a PostDoc at Harvard University from 1996 to 1998 in Synthetic Chemistry. Kirk then obtained a Ph.D. in Organic Chemistry from UC Santa Barbara between 1991 and 1996. Finally, Kirk Stevens completed a B.S. in Chemistry from Reed College between 1986 and 1991.